Positionspapier: Anwendung von Biologika bei chronischer Rhinosinusitis mit Polyposis nasi (CRSwNP) im deutschen Gesundheitssystem
- 24 September 2021
- journal article
- research article
- Published by Springer Science and Business Media LLC in Allergo Journal
- Vol. 30 (6), 24-44
- https://doi.org/10.1007/s15007-021-4872-z
Abstract
No abstract availableKeywords
This publication has 119 references indexed in Scilit:
- Innate lymphoid cells responding to IL-33 mediate airway hyperreactivity independently of adaptive immunityJournal of Allergy and Clinical Immunology, 2012
- Differential expression of interleukin‐32 in chronic rhinosinusitis with and without nasal polypsAllergy, 2011
- TH2 heterogeneity: Does function follow form?Journal of Allergy and Clinical Immunology, 2010
- Evidence for altered activity of the IL-6 pathway in chronic rhinosinusitis with nasal polypsJournal of Allergy and Clinical Immunology, 2010
- Heterogeneity of human effector CD4+ T cellsArthritis Research & Therapy, 2009
- A novel IL-1 family cytokine, IL-33, potently activates human eosinophilsJournal of Allergy and Clinical Immunology, 2008
- Evidence of a role for B cell–activating factor of the TNF family in the pathogenesis of chronic rhinosinusitis with nasal polypsJournal of Allergy and Clinical Immunology, 2008
- IL-32, a novel cytokine with a possible role in diseaseAnnals Of The Rheumatic Diseases, 2006
- Mycobacterium tuberculosis Induces Interleukin-32 Production through a Caspase- 1/IL-18/Interferon-γ-Dependent MechanismPLoS Medicine, 2006
- Disruption of the murine IL-4 gene blocks Th2 cytokine responsesNature, 1993